EDRH
UTHR icon

Edmond de Rothschild Holding’s United Therapeutics UTHR Stock Holding History

Edmond de Rothschild Holding’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Buy
+848
New +$478K 0.01% 380

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Edmond de Rothschild Holding's UTHR Position: Q2 2026 in Review

Edmond de Rothschild Holding opened a new position in United Therapeutics (UTHR) in Q2 2026: 848 shares worth $459K. The stake represents 0.01% of the portfolio and ranks #380 among its holdings.

875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Edmond de Rothschild Holding held 848 shares of United Therapeutics worth $459K as of Q2 2026.
  • United Therapeutics was a new Edmond de Rothschild Holding position in Q2 2026.
  • United Therapeutics made up 0.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #380 holding.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.